Skip to main content
Home

Main navigation

  • About Us
    • About Us
    • Board of Directors
    • Compliance
  • Commitment
    • Innovation Hub
  • Products
    • EXPAREL
    • ioveraº
    • DepoFoam
  • Partnerships
    • Partnerships for the Future
    • Grants and Corporate Giving
  • News
    • In the News
    • Archive
  • Events
  • Investors
    • Overview
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
  • Careers
  • Home
  • Innovation Hub

This Section is Intended for US Health Care Professionals Only

Select the option that best describes you:

US Health Care
Professional
Patient or Caregiver

This section is intended for US residents. Non-US residents click here.

Ambulatory Surgery

Reimbursement in the
ASC Setting

Reimbursement in the
ASC Setting

CMS Ruling on
Outpatient Joints

CMS Ruling on
Outpatient Joints

The Role of Enhanced Recovery and Regional Anesthesia to Support the Anticipated Surge in ASC Procedures

The Role of Enhanced Recovery and Regional Anesthesia to Support the Anticipated Surge in ASC Procedures

Regional Anesthesia and Outpatient Surgery

Regional Anesthesia and Outpatient Surgery

Back to Innovation Hub Stay Informed

ASC, ambulatory surgery center; CMS, Centers for Medicare & Medicaid Services.

The Pacira Website is Intended for US Residents Only

Are you a US Resident?

Yes
No

Stay Informed About Updates to the Innovation Hub

*Required field

Submit
By clicking submit, you agree to be contacted by Pacira BioSciences, Inc. For more details, please review our Privacy Notice.
  • Contact Us
  • Legal
  • Site Map
  • Privacy Notice

EXPAREL® (bupivacaine liposome injectable suspension), the EXPAREL logo, ioverao, the ioverao logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.

©2021 Pacira BioSciences, Inc.